Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.


Updates from The Motley Fool

Latest updates on Bristol-Myers Squibb from Fool.com.  The Fool has written over 1000 articles on Bristol-Myers Squibb.


Stock Performance

View Interactive BMY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bristol-Myers Squibb.
Current Price: $50.84
Prev Close: $50.13
Open: $50.44
Bid: $50.83
Ask: $50.84
Day's Range: $50.13 - $50.98
52wk Range: $44.30 - $68.88
Volume: 10,037,900
Avg Vol 16,598,595
Market Cap: $83B
P/E (ttm): 16.54
EPS (ttm): $3.03
Div & Yield: $1.64 (3.3%)

Company Rating

What our community thinks about Bristol-Myers Squibb.
CAPS Rating 4 out of 5
 
1742 Outperform
117 Underperform
CAPS All Stars
 
377 Outperform
19 Underperform

How do you think Bristol-Myers Squibb will perform against the market?



You pick for Bristol-Myers Squibb is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Giovanni Caforio, CEO

82% Approve

Based on 445 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Bristol-Myers Squibb.

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers